This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Evaluation of PKU UP

Sponsored by Vitaflo International, Ltd

About this trial

Last updated 8 months ago

Study ID

PKU-PAED-LIQ-2022-10-07

Status

Recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
1 to 10 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Started a year ago

What is this trial about?

PKU UP is a prospective, single-arm, open-label, 26-week acceptability study to evaluate PKU UP for the dietary management of participants with phenylketonuria (PKU). Up to 15 participants aged 1 - 10 years old will be recruited and it is anticipated the study will open in at least three sites in the United Kingdom (UK) to recruit the target number of participants in the required timeframe.

What are the participation requirements?

Yes

Inclusion Criteria

- Diagnosis of PKU requiring a low-protein diet and protein substitute.

- Participants who are adherent with their blood phenylalanine (Phe) testing, in the opinion of the investigator.

- Participants aged 1-10 years.

- Participants who in the opinion of the investigator are anticipated to be able to take at least half of their daily protein equivalent requirement from PKU UP (in order to assess this, a taste test (or similar) may be conducted at investigator's discretion as part of the screening process).

- Willingly given, written, informed consent from the parent(s)/guardian(s).

- Willingly given, written assent by the participant (if appropriate).

No

Exclusion Criteria

- Inability to comply with the study protocol, in the opinion of the investigator.

- Any co-morbidity, which, in the opinion of the investigator, would preclude participation in the study.

- Diagnosis of persistent hyperphenylalaninemia, or mild PKU not requiring a low protein diet and protein substitute.

- Allergy or intolerance to milk.

- Participants who are currently participating in, plan to participate in or have participated in an interventional investigational drug, food or medical device study within 30 days prior to the screening visit.

- Use of additional micronutrient supplements during the evaluation period, unless clinically indicated and prescribed by the Investigator (must be recorded in both the medical records and case report form).

Locations

Location

Status

Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting